Better stability of acenocoumarol compared to warfarin treatment in one-year observational, clinical study in patients with nonvalvular atrial fibrillation

Better stability of acenocoumarol compared to warfarin treatment in one-year observational, clinical study in patients with nonvalvular atrial fibrillation

Aim To evaluate differences in the treatment quality between often used oral anticoagulants, warfarin and acenocoumarol in patients with nonvalvular atrial fibrillation (NVAF). Methods This was an observational, comparative, one-year clinical study, conducted in the Blood Transfusion Institute of Sa...

Full description

Bibliographic Details
Main Authors:	Lejla Burnazović-Ristić, Maida Rakanović-Todić, Fahir Bečić, Elvedina Kapić, Jasna Kusturica, Aida Kulo, Amila Mehmedović, Orhan Lepara, Nedžad Mulabegović
Format:	Article
Language:	English
Published:	Medical Association of Zenica-Doboj Canton 2011-02-01
Series:	Medicinski Glasnik
Subjects:	nonvalvular atrial fibrillation warfarin acenocoumarol INR stability
Online Access:	http://www.ljkzedo.com.ba/medglasnik/vol81/MGvol81.2011_2.pdf

Similar Items

Genotype-phenotype correlations in patients treated with acenocoumarol / Corelaţii genotip-fenotip la pacienţii trataţi cu acenocumarol
by: Militaru Florentina Claudia, et al.
Published: (2014-09-01)

Healthcare resources and costs associated with nonvalvular atrial fibrillation in Spain: apixaban versus acenocoumarol
by: Josep Comin Colet, et al.
Published: (2023-07-01)

Interaction of food supplement L-carnitine with oral anticoagulant acenocoumarol
by: HU Bachmann
Published: (2004-06-01)

Comparison of Anticoagulation Quality between Acenocoumarol and Warfarin in Patients with Mechanical Prosthetic Heart Valves: Insights from the Nationwide PLECTRUM Study
by: Danilo Menichelli, et al.
Published: (2021-03-01)

Efficiency and effectiveness of the use of an acenocoumarol pharmacogenetic dosing algorithm versus usual care in patients with venous thromboembolic disease initiating oral anticoagulation: study protocol for a randomized controlled trial
by: Carcas Antonio J, et al.
Published: (2012-12-01)

A Pharmacogenetically Guided Acenocoumarol Dosing Algorithm for Chilean Patients: A Discovery Cohort Study
by: Angela Roco, et al.
Published: (2020-04-01)

Incidence and cost of bleeding events requiring hospitalization in patients with atrial fibrillation treated with acenocoumarol in Greece
by: Georgia Kourlaba, et al.
Published: (2021-05-01)

Topical treatment of standardised burns with herbal remedies in model rats
by: Fahir Bečić, et al.
Published: (2005-11-01)

Modern Approach in Treatment of Diabetes Insipidus
by: Elvedina Kapić, et al.
Published: (2005-05-01)

Effect of met-enkephalin on chromosomal aberrations in the lymphocytes of the peripheral blood of patients with multiple sclerosis
by: Maida Rakanović-Todić, et al.
Published: (2014-05-01)

Acenocoumarol Pharmacogenetic Dosing Algorithm versus Usual Care in Patients with Venous Thromboembolism: A Randomised Clinical Trial
by: Hoi Yan Tong, et al.
Published: (2021-06-01)

Successful outcome with outpatient acenocoumarol therapy for echocardiographically visible pulmonary thrombus
by: Karanam Gowrinath, et al.
Published: (2021-01-01)

OPINION SURVEY OF THE CARDIOLOGISTS IN BULGARIA REGARDING THERAPY WITH ACETYLSALICYLIC ACID, CLOPIDOGREL AND ACENOCOUMAROL IN PATIENTS UNDERGOING DENTAL EXTRACTIONS
by: Atanaska Dinkova, et al.
Published: (2017-10-01)

Whether Warfarin Therapy is Associated with Damage on Renal Function in Chinese Patients with Nonvalvular Atrial Fibrillation
by: Yu Kong, et al.
Published: (2016-01-01)

OPINION SURVEY OF THE GENERAL PRACTITIONERS IN BULGARIA REGARDING THERAPY WITH ACETYLSALICYLIC ACID, CLOPIDOGREL AND ACENOCOUMAROL IN PATIENTS UNDERGOING DENTAL EXTRACTIONS
by: Atanaska Dinkova, et al.
Published: (2017-11-01)

Acenocoumarol, an Anticoagulant Drug, Prevents Melanogenesis in B16F10 Melanoma Cells
by: Hyunju Han, et al.
Published: (2023-04-01)

The Association Between Long-Term Acenocoumarol Treatment and Vitamin D Deficiency
by: Jolanta Sawicka-Powierza, et al.
Published: (2018-05-01)

Acenocoumarol Exerts Anti-Inflammatory Activity via the Suppression of NF-κB and MAPK Pathways in RAW 264.7 Cells
by: Hyun-Ju Han, et al.
Published: (2023-02-01)

The VKORC1 and CYP2C9 gene variants as pharmacogenetic factors in acenocoumarol therapy in Serbian patients - consideration of hypersensitivity and resistance
by: Rakićević Ljiljana, et al.
Published: (2022-01-01)

Efficacy and safety of rivaroxaban in prevention and therapy of thromboembolic events in patients with nonvalvular atrial fibrillation
by: Tamara Kovačević Preradovic, et al.
Published: (2023-01-01)

Traditional warfarin (Coumadin) therapy usage experience on nonvalvular atrial fibrillation before non-Vitamin K antagonists (new oral anticoagulants) era from a center in Turkey
by: Emre Ozdemir, et al.
Published: (2020-01-01)

Comparisons of Methods and Outcomes of Warfarin Guideline-based Management in Patients on Warfarin Therapy whose International Normalized Ratio (INR) is Higher than Target INR at Vachiraphuket Hospital
by: Tulaya Potaros, et al.
Published: (2018-08-01)

Nine‐year trend of oral anticoagulant use in patients with embolic stroke due to nonvalvular atrial fibrillation
by: Chisa Asahina, et al.
Published: (2020-10-01)

Incidence of cerebral microembolization in patients with nonvalvular atrial fibrillation using transcranial Doppler
by: Hamouda A.K.H El-Bahnasy, et al.
Published: (2022-01-01)

The impact of aripiprazole on INR in a psychotic patient during warfarin therapy
by: Taha Can Tuman
Published: (2018-10-01)

Effect of olanzapine treatment on INR of a patient receiving warfarin therapy
by: Derya Arslan, et al.
Published: (2016-06-01)

Effect of olanzapine treatment on INR of a patient receiving warfarin therapy
by: Derya Arslan, et al.
Published: (2016-06-01)

Moxifloxacin-warfarin interaction
by: Yan Ji, et al.
Published: (2012-01-01)

RANDOMIZED COMPARISON OF TWO APPROACHES TO WARFARIN DOSAGE IN CARDIOVASCULAR HOSPITAL SECTION
by: L. N. Mishchenko, et al.
Published: (2015-08-01)

Characteristics of Japanese Patients with Nonvalvular Atrial Fibrillation on Anticoagulant Treatment: A Descriptive Analysis of J-dabigatran Surveillance and JAPAF Study
by: Yukihiro Koretsune, et al.
Published: (2019-02-01)

The safety of antithrombotic therapy in patients with cerebral microbleeds and cardiogenic cerebral embolism due to nonvalvular atrial fibrillation
by: Jiayu Wang, et al.
Published: (2019-04-01)

One-year clinical outcome of patients with nonvalvular atrial fibrillation: Insights from KERALA-AF registry
by: C.G. Bahuleyan, et al.
Published: (2021-01-01)

Genetic and Non-Genetic Factors Impact on INR Normalization in Preprocedural Warfarin Management
by: Eljilany I, et al.
Published: (2021-08-01)

Postmarketing surveillance on clinical use of edoxaban in patients with nonvalvular atrial fibrillation (ETNA‐AF‐Japan): Three‐month interim analysis results
by: Takeshi Yamashita, et al.
Published: (2019-02-01)

Warfarin Quality Metrics for Hospitalized Older Adults
by: Jessica Cohen, et al.
Published: (2018-07-01)

Characteristics of patients with thromboembolic disorders on warfarin therapy in resource limited settings
by: Zipporah Kamuren, et al.
Published: (2018-09-01)

A survey of reasons for continuing warfarin therapy in the era of direct oral anticoagulants in Japanese patients with atrial fibrillation: the SELECT study
by: Ikeda T, et al.
Published: (2018-01-01)

Type 2 diabetes mellitus and nonvalvular atrial fibrillation in Mexico: national registries raise a red flag
by: Manlio F. Márquez-Murillo, et al.
Published: (2023-10-01)

THE CONTROL OF INTERNATIONAL NORMALISED RATIO IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH WARFARIN IN OUTPATIENT AND HOSPITAL SETTINGS: DATA FROM RECVASA REGISTRIES
by: M. M. Loukianov, et al.
Published: (2018-03-01)

Incidence and risk factors of warfarin therapy complications in community hospitals, central and eastern regions, Thailand: a retrospective, multicenter, cohort study
by: Benyapha Sombat, et al.
Published: (2023-06-01)